Profiling of differentially expressed genes in human uterine leiomyomas

被引:33
作者
Lee, E. -J.
Kong, G.
Lee, S. -H.
Rho, S. B.
Park, C. -S.
Kim, B. -G.
Bae, D. -S.
Kavanagh, J. J.
Lee, J. -H.
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Obstet & Gynecol,Div Gynecol Oncol, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Mol Therapy Res Ctr, Seoul 135710, South Korea
[3] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea
[4] Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Med Oncol, Houston, TX 77030 USA
关键词
cDNA microarray; immunohistochemistry; RT-PCR; uterine leiomyoma;
D O I
10.1111/j.1048-891x.2005.15016.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uterine leiomyomas are very common benign tumors resulting in clinically serious gynecological problems in women of reproductive age. Approximately, 1% of leiomyosarcoma was reported to arise in a preexisting leiomyoma. However, the molecular basis of these tumors is poorly understood. To understand the molecular changes during leiomyoma development, we profiled differentially expressed genes in ten paired leiomyoma and normal myometrial tissues using cDNA microarray chip analysis. We identified 67 genes (27 overexpressed and 40 underexpressed) which were scored as differentially expressed at least twofold in at least eight of ten patients. Eighteen of 67 genes have been already reported to be differentially expressed without their established functions in uterine leiomyoma and others have never been reported. Subsequently, the relative expression levels of representative genes from identified 67 genes were confirmed by reverse-transcriptase polymerase chain reaction and immunohistochemistry and were found to be consistent with the microarray data. This study could provide a new insight into the understanding of leiomyoma and leiomyosarcoma.
引用
收藏
页码:146 / 154
页数:9
相关论文
共 34 条
  • [1] Impairment of adenylate cyclase activity and G-proteins in human uterine leiomyoma
    Bajo, A
    Carrero, I
    Hrïstov, RL
    Valenzuela, P
    Martínez, P
    Cortés, J
    Prieto, JC
    Guijarro, LG
    [J]. TISSUE & CELL, 2000, 32 (05) : 399 - 404
  • [2] IDENTIFICATION OF A GENE FAMILY REGULATED BY TRANSFORMING GROWTH-FACTOR-BETA
    BRUNNER, A
    CHINN, J
    NEUBAUER, M
    PURCHIO, AF
    [J]. DNA AND CELL BIOLOGY, 1991, 10 (04) : 293 - 300
  • [3] The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy
    Chegini, N
    Luo, XP
    Ding, L
    Ripley, D
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 209 (1-2) : 9 - 16
  • [4] Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy
    Chegini, N
    Verala, J
    Luo, XP
    Xu, JX
    Williams, RS
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2003, 10 (03) : 161 - 171
  • [5] Eid MA, 1998, CANCER RES, V58, P2461
  • [6] IDENTIFICATION OF A YAC SPANNING THE TRANSLOCATION BREAKPOINTS IN UTERINE LEIOMYOMATA, PULMONARY CHONDROID HAMARTOMA, AND LIPOMA - PHYSICAL MAPPING OF THE 12Q14-Q15 BREAKPOINT REGION IN UTERINE LEIOMYOMATA
    FEJZO, MS
    YOON, SJ
    MONTGOMERY, KT
    REIN, MS
    WEREMOWICZ, S
    KRAUTER, KS
    DORMAN, TE
    FLETCHER, JA
    MAO, JI
    MOIR, DT
    KUCHERLAPATI, RS
    MORTON, CC
    [J]. GENOMICS, 1995, 26 (02) : 265 - 271
  • [7] GLOUDEMANS T, 1990, CANCER RES, V50, P6689
  • [8] Hao MW, 2002, WORLD J GASTROENTERO, V8, P203
  • [9] EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II GENES IN HUMAN SMOOTH-MUSCLE TUMORS
    HOPPENER, JWM
    MOSSELMAN, S
    ROHOLL, PJM
    LAMBRECHTS, C
    SLEBOS, RJC
    DEPAGTERHOLTHUIZEN, P
    LIPS, CJM
    JANSZ, HS
    SUSSENBACH, JS
    [J]. EMBO JOURNAL, 1988, 7 (05) : 1379 - 1385
  • [10] Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.3.CO